Rising Prevalence Of Infectious Diseases Driving The Growth Of The Market Due To Increasing Risk Of Infections Leading To Pleural Complications: A Significant Driver Propelling The Pleural Diseases Market In 2025

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Pleural Diseases Market Size and Projected Growth Rate?
The market for pleural diseases has seen significant expansion in recent times. The growth is projected to escalate from a market value of $4.86 billion in 2024 to $5.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.6%. Factors contributing to the growth in the past period include an increased occurrence of pleural effusion, heightened awareness of pleural diseases, an accentuated focus on early diagnosis, a rise in healthcare facilities, and an increase in clinical trials for pleural diseases.

Expectations are high for robust expansion of the pleural diseases market size in the coming years. The market is projected to escalate to $6.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.3%. The projected growth can be credited to factors such as an increased prevalence of pleural diseases, an aging population, a rise in occupational hazards, an increasing number of clinical trials, and a growing number of diagnostic centers. Significant trends to watch during this forecast period include progress in diagnostic measures, advancements in diagnostic tools, the uptake of minimally invasive procedures, enhanced drug development, and the increased acceptance of telemedicine.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

What Are the Major Segments in the Pleural Diseases Market?
The pleural diseases market covered in this report is segmented -

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types
2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions
3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy
4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:
1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy
2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax
3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma
4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma
5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

What Are The Driving Pleural Diseases Market Evolution?
The escalating pervasiveness of infectious diseases is predicted to boost the expansion of the pleural diseases market in the future. Infectious diseases, triggered by harmful micro-organisms like bacteria, viruses, fungi, or parasites, are health conditions whose growing prevalence is shaped by changes in the environment, human behavior, and advances in worldwide travel. Diseases such as bacterial pneumonia, tuberculosis, or viral infections can lead to pleural disease through provoking inflammation, infection, or the buildup of fluid in the pleural cavity. For instance, data from the National Library of Medicine, a US-based research and information medical library, in January 2023 showed that infectious diseases are responsible for more than 52 million fatalities every year, thereby potentially affecting half the global population. Furthermore, each year, roughly 14 million fatalities occur among children under five, with 70% of these deaths being preventable through immunization. As such, the ongoing rise in infectious diseases stimulates the progression of the pleural diseases market.

Which Firms Dominate The Pleural Diseases Market Segments?
Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

What Trends Are Expected to Dominate the Pleural Diseases Market in the Next 5 Years?
Leading organizations in the pleural diseases market are concentrating on the production of innovative treatment methodologies, such as ready-to-use injectable therapies, to enhance patient convenience, reduce preparation time, and limit dosing mistakes. These injectable treatments are already formulated and diluted, eliminating the need for any mixing or reconstitution prior to usage, thus guaranteeing accuracy, convenience, and shortened preparation time. For instance, US-based Amneal Pharmaceuticals released PEMRYDI RTU, the first-ever ready-to-use pemetrexed for injection in April 2024. This product serves individuals with pleural diseases by offering an easy, ready-to-use treatment solution that does away with the need for dilution or reconstitution, cuts down preparation time, brings down the possibility of dosing errors, and enhances the availability of efficient treatment for diseases like malignant pleural mesothelioma.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Is The Largest Region In The Pleural Diseases Market?
North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pleural Diseases Market?
2. What is the CAGR expected in the Pleural Diseases Market?
3. What Are the Key Innovations Transforming the Pleural Diseases Industry?
4. Which Region Is Leading the Pleural Diseases Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.